UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044043
Receipt number R000050289
Scientific Title Measurement of the effect of light stimulation on brain waves and daily rhythm
Date of disclosure of the study information 2021/07/01
Last modified on 2023/10/28 09:17:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Measurement of the effect of light stimulation on brain waves and daily rhythm

Acronym

Misasa Study

Scientific Title

Measurement of the effect of light stimulation on brain waves and daily rhythm

Scientific Title:Acronym

Misasa Study

Region

Japan


Condition

Condition

Aging

Classification by specialty

Geriatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to investigate the effects of light stimulation on brain waves and life rhythms in elderly people.

Basic objectives2

Others

Basic objectives -Others

The aim of this study is to investigate the effects of light stimulation on circadian rhythm and sleep in elderly people.

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Measurement of changes in sleep construction before and after light stimulation in the elderly

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

light exposure for 3 hours during the daytime for 10 days.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Elderly people over 65 years old who are hospitalized for rehabilitation
2) People who have been fully informed about the study and have given written consent of their own free will with full understanding.

Key exclusion criteria

1)People with poorly controlled cardiovascular, endocrine, cerebral, neurological or psychiatric diseases that may affect the outcome of the study.
2)People with alcohol dependence or excessive drinking habits.
3)Those with serious liver disease (AST (GOT) or ALT (GPT) of 100 U or more)
4)Those with serious renal disease (BUN > 25 mg/dL or serum creatinine > 2.0 mg/dL)
5)People with a habit of taking drugs or supplements that affect sleep
6)People with a history or family history of photosensitive seizures
7)Those who are judged by the principal investigator to be inappropriate
8)Those who have refused to give consent

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Masanori
Middle name
Last name Fujii

Organization

Okayama University Hospital

Division name

Department of Allergy and Respiratory Medicine

Zip code

700-8558

Address

2-5-1 Shikata-cho, Kita-ku, Okayama City, Okayama, Japan

TEL

+81-86-235-7227

Email

feynman8@okayama-u.ac.jp


Public contact

Name of contact person

1st name Masanori
Middle name
Last name Fujii

Organization

Okayama University Hospital

Division name

Department of Allergy and Respiratory Medicine

Zip code

700-8558

Address

2-5-1 Shikata-cho, Kita-ku, Okayama City, Okayama, Japan

TEL

+81-86-235-7227

Homepage URL


Email

feynman8@okayama-u.ac.jp


Sponsor or person

Institute

Okayama University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee

Address

2-5-1 Shikata-cho, Kita-ku, Okayama City, Okayama, Japan

Tel

+81-86-235-6938

Email

mae6605@adm.okayama-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 04 Month 20 Day

Date of IRB

2021 Year 06 Month 22 Day

Anticipated trial start date

2021 Year 06 Month 22 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 04 Month 26 Day

Last modified on

2023 Year 10 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050289


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name